Home›People›Andrew Bellinger
AB

Andrew Bellinger

Director at AI3 Bio, Inc.

Director
Updated Nov 6, 2026·Latest SEC filing Oct 20, 2025·Suggest an edit

About Andrew Bellinger

Andrew Bellinger is a director of AI3 Bio, Inc.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Bellinger in the role, so the role may have started earlier or lasted longer.

AI3 Bio, Inc. Current
Director
2024 – Present · Watertown, MA
ai3Bio develops lipid nanoparticle and antibody drugs that remove the T cells driving autoimmune disease, for patients living with these conditions.

Key Colleagues at Startups

The people Andrew Bellinger works with at each company, as listed on that company's latest Form D.

AI3 Bio, Inc. · Form D, Oct 20, 2025
AE
Alan Ezekowitz
Board Director
NS
Nick Seaver
CFO/CBO, Board Director
Jonathan Kagan
Jonathan Kagan
Distinguished Scientist and director
Steven Altschuler
Steven Altschuler
CEO, Board Director
RM
AC
Andrew Cornforth
Executive officer
NG
Nichols Garrett
Executive officer

Sources

  1. SECAI3 Bio, Inc. Form D, filed Oct 20, 2025